Replies to post #16594 on The Rising Influence of Rising Affluence

[biotech_researcher]

Pfizer's revenue was up only 1%, so that is a show stopper for me. They can always finagle earnings I suppose..

Pfizer's Q1 net jumps 14 pct., sales just miss expectations
Published 3 Hours Ago
The Associated Press
Pfizer posted slightly higher sales and a 14 percent jump in profit in the first quarter, thanks to lower restructuring costs and a much-lower tax rate, but its revenue still missed Wall Street expectations.
The maker of pain medicine Lyrica and the blockbuster Prevnar 13 vaccine against pneumococcal infections said Tuesday that net income was $3.56 billion, or 59 cents per share. That was up from $3.12 billion, or 51 cents per share, a year earlier, when there were more shares being publicly traded.
The New York company's earnings, adjusted for non-recurring costs, came to 77 cents per share. That was 3 cents better than industry analysts had expected, according to a survey by Zacks Investment Research.

Revenue totaled $12.91 billion, up 1 percent but short of the $13.09 billion analysts had projected.